Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
about
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsHuman Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseNatural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceChronic alcohol abuse and HIV disease progression: studies with the non-human primate modelMonocytes as regulators of inflammation and HIV-related comorbidities during cARTCommon transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple SclerosisDopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesisAnti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infectionNeurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapyComputational modeling reveals distinct effects of HIV and history of drug use on decision-making processes in womenDopamine receptor activation increases HIV entry into primary human macrophagesMeloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female ratsHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Neural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial.Defining cognitive impairment in people-living-with-HIV: the POPPY study.A Smartphone App to Screen for HIV-Related Neurocognitive ImpairmentMobile Phone Ecological Momentary Assessment of Daily Stressors Among People Living With HIV: Elucidating Factors Underlying Health-Related Challenges in Daily Routines.Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease.Gene expression patterns associated with neurological disease in human HIV infectionHIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Evidence of the innate antiviral and neuroprotective properties of progranulin.Intercellular Adhesion Molecular-5 as Marker in HIV Associated Neurocognitive Disorder.Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersHIV Clade-C Infection and Cognitive Impairment, Fatigue, Depression, and Quality of Life in Early-Stage Infection in Northern Indians.The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.Cross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging.HIV-associated neurocognitive disorder.Neurocognitive function in HIV-infected patients: comparison of two methods to define impairmentSignificant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disordersHIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells.Exploring Substance Use and HIV Treatment Factors Associated with Neurocognitive Impairment among People Living with HIV/AIDS.Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsRoutine detection and management of neurocognitive impairment in HIV-positive patients in a UK centreDiffusion tensor and volumetric magnetic resonance measures as biomarkers of brain damage in a small animal model of HIV.HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS ProjectThe definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection.
P2860
Q24631745-6B8DDE50-FED6-4D61-A088-52958B8E3A7AQ26740117-234878D4-BDD3-479A-B904-3BE620FA90C4Q26770397-C9B00BBA-AFBE-4F70-B015-5BF171239297Q26770401-12CD7692-F982-44C4-A793-E2DA76BE6E20Q26825762-E3526E60-B7D0-45AD-912B-17F63244A990Q26852432-14F387CD-FC40-4F4E-9D40-6B8DC8920E37Q27006827-37CF99A2-B6C7-4412-8844-198FC014C62FQ27007041-C02B60BE-C3FA-4E29-BF78-112C5E604FB5Q27316037-2623D33B-BCE0-4935-91FE-D9E7939E9CAEQ27322602-CE6711E9-B3A8-4006-92CA-16CA7B95DABEQ28534903-66282E8F-BA03-43D7-A01A-506DE2D41685Q28535185-20B03D10-2D05-4F54-9E5F-4FB9429DCA86Q28543414-81F196F7-7F1F-4078-945F-496AF324A62CQ28543458-3FD135FD-F169-4153-88A7-ADC4B0C555EDQ30234305-E88847AB-36CC-40C4-B410-135282DB2C10Q30391907-5B7E72BE-079F-4688-AD90-930332F03336Q30826784-4BEC8B71-8747-4F1D-B9B9-0FDCA8AEF769Q33440991-6B57948E-FF05-41F6-8D45-1454404D2041Q33454710-978E7B00-835A-49FB-8CF9-559A1FD24620Q33603457-5AA1CC25-8BD0-466E-A38F-D1E52026CA49Q33605737-3739EE8D-C73F-421E-A026-E46ADDF95DD3Q33647438-1F00D1C8-5F0F-4234-8D17-B67773026958Q33690042-C023A505-6C35-4503-9F31-8DB6DB3CE9BCQ33714228-A6619575-1540-4523-9BFC-7EB51D38669CQ33734695-28F7E5E6-6A0B-4E16-AACA-81E4A9FC24B2Q33737734-E83FCF08-6553-4FDA-B710-64A2F90767D1Q33745361-AF87DDBB-F5BD-46CA-884A-B046F0482355Q33820078-39303796-992C-4492-A9AE-0D206D475BCAQ33939729-02FBBE1A-B894-43F9-BAC4-FDF3F0B139C0Q33982015-15765190-49DF-44E6-B7EF-63E9575E997BQ34016222-A3EB6DB2-4745-4E29-9FE7-1D9708DFA477Q34017780-534F3D43-E654-455F-9481-FA0D563B6773Q34024194-99A1B71B-6901-43F1-9328-91BAA6FA4D82Q34048920-B433955D-AD0C-4504-AA1A-F972F77284E4Q34065983-E67690BB-150D-482B-A36D-D97A5CAF33D4Q34075695-37D31DE3-FAE7-417F-BCB1-DEC219C9381BQ34076133-459808CC-6F7A-4A40-A0E0-E48A4D38E49FQ34113072-F70A9727-48DC-45AC-B4B8-557A5C16A6E6Q34113118-85FE0B7A-EB5D-4401-B941-496E6BDF444EQ34125271-AB686A35-2A4E-45F4-92C1-46883B3A13DD
P2860
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
description
article
@en
im Dezember 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2009
@uk
name
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
@en
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
@nl
type
label
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
@en
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
@nl
prefLabel
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
@en
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
@nl
P2093
P50
P1433
P1476
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
@en
P2093
Aline Rimbault Abraham
Ezio Giacobini
Isabelle Bourquin
Jean-Marie Annoni
Jean-Philippe Chave
Samanta Simioni
Véronique Schiffer
P356
10.1097/QAD.0B013E3283354A7B
P407
P577
2009-12-01T00:00:00Z